Real-time enrollment status for this pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 5:50 PM UTC
| NCT Number | NCT05296421 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma |
| Phase | NA |
| Target Enrollment | 16 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Rutgers, The State University of New Jersey |
| Last Updated on CT.gov | May 4, 2026 (May 4, 2026) |
As of July 19, 2026: Clinical trial NCT05296421 is currently recruiting participants. This na study for pancreatic ductal adenocarcinoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Rutgers, The State University of New Jersey. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05296421 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05296421 was last updated May 4, 2026 (May 4, 2026). HelloStudys verifies this status automatically.